• 1
    Colom F, Vieta E. Treatment adherence in bipolar patients. Clinical Approaches Bipolar Disorders 2002; 1: 4956.
  • 2
    Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48: 10821088.
  • 3
    Scott J. Predicting medication non-adherence in severe affective disorders. Acta Neuropsychiatr 2000; 12: 128130.
  • 4
    Muller-Oerlinghausen B, Muser-Causemann B, Volk J. Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. J Affect Disord 1992; 25: 261269.
  • 5
    Frank E, Prien RF, Kupfer DJ, Alberts L. Implications of noncompliance on research in affective disorders. Psychopharmacol Bull 1985; 21: 3742.
  • 6
    GoodwinFK, JamisonKR eds. Manic-depressive Illness. New York: Oxford University Press, 1990.
  • 7
    Jamison KR, Gerner RH, Goodwin FK. Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry 1979; 36 (8 Spec No): 866869.
  • 8
    Miklowitz DJ. Longitudinal outcome and medication noncompliance among manic patients with and without mood-incongruent psychotic features. J Nerv Ment Dis 1992; 180: 703711.
  • 9
    Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated to treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000; 61: 549555.
  • 10
    Maarbjerg K, Aagaard J, Vestergaard P. Adherence to lithium prophylaxis: I. Clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry 1988; 21: 121125.
  • 11
    Comtois KA, Ries R, Armstrong HE. Case manager ratings of the clinical status of dually diagnosed outpatients. Hosp Community Psychiatry 1994; 45: 568573.
  • 12
    Weiss RD, Greenfield SF, Najavits LM et al. Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry 1998; 59: 172174.
  • 13
    Shemesh E, Yehuda R, Milo O et al. Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med 2004: 66: 521526.
  • 14
    Schumann C, Lenz G, Berghofer A, Muller-Oerlinghausen B. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res 1999; 89: 247257.
  • 15
    Perlick DA, Rosenheck RA, Kaczynski R, Kozma L. Medication non-adherence in bipolar disorder: a patient-centered review of research findings. Clin Approach Bipolar Disord 2004; 3: 5664.
  • 16
    Sajatovic M, Hrouda D, Davies M. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatr Serv 2004; 55: 264269.
  • 17
    American Psychiatric Association. Practice Guideline for the Treatment of Patients with Bipolar Disorder (Revision). Washington, DC: American Psychiatric Press, 2002.
  • 18
    Nemeroff CB. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry 2000; 61 (Suppl. 13): 1925.
  • 19
    Calabrese JR, Shelton MD, Rapport DJ, Kimmel SE. Bipolar disorders and the effectiveness of novel anticonvulsants. J Clin Psychiatry 2002; 63 (Suppl. 3): 59.
  • 20
    Keck PE, Perlis RH, Otto MW, Carpenter D, Ross R, Docherty JP. The Expert Consensus Guideline Series: Treatment of Bipolar Disorder 2004. Postgraduate Medicine Special Report 2004; December: 1116.
  • 21
    Gilmer TP, Dolder CR, Lacro JP et al. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. Am J Psychiatry 2004; 161: 692699.
  • 22
    Svarstad BL, Shireman TI, Sweeney JK. Using drug claims data to assess the relationship of medication adherence with hospitalization and costs. Psychiatr Serv 2001; 52: 805811.
  • 23
    Valenstein M, Blow FC, Copeland LA et al. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors. Schizophr Bull 2004; 30: 255264.
  • 24
    Valenstein M, Copeland LA, Blow FC et al. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002; 40: 630639.
  • 25
    DiMatteo MR. Variations in patients adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42: 200209.
  • 26
    Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27: 12181224.
  • 27
    Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002; 105: 164172.
  • 28
    Mukherjee S, Rosen AM, Shukla S. Acceptance by patients of maintenance lithium treatment. Lithium 1993; 2: 6369.
  • 29
    Jamison KR. Medication compliance. In: GoodwinFK, JamisonKR, eds. Manic Depressive Illness. Oxford: Oxford University Press, 1990: 756757.
  • 30
    Lenzi A, Lazzerini F, Placidi GF, Cassano GB, Akiskal HS. Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Pharmacopsychiatry 1989; 22: 3437.
  • 31
    Keck PE Jr, McElroy SL, Strakowski SM, Bourne ML, West SA. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 1997; 33: 8791.
  • 32
    Connelly CE, Davenport YB, Nurnberger JI Jr. Adherence to treatment regimen in a lithium carbonate clinic. Arch Gen Psychiatry 1982; 39: 585588.
  • 33
    Kucera-Bozarth K, Beck NC, Lyss L. Compliance with lithium regimens. J Psychosoc Nurs Ment Health Serv 1982; 20: 1115.
  • 34
    Danion JM, Neunreuther C, Krieger-Finance F, Imbs JL, Singer L. Compliance with long-term lithium treatment in major affective disorders. Pharmacopsychiatry 1987; 20: 230231.
  • 35
    Sajatovic M, Davies M, Bauer MS, McBride L, Hays RW, Jenkins J. Attitudes regarding the collaborative practice model and treatment adherence among individuals with bipolar disorder. Compr Psychiatry 2005; 46: 2727.
  • 36
    Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 2002; 63: 384390.
  • 37
    Keck PE Jr, McElroy SL, Strakowski SM et al. Factors associated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry 1996; 57: 292297.
  • 38
    Sajatovic M, Bauer M, Kilbourne A, Vertrees J, Williford W. Self-reported medication adherence among veterans with bipolar disorder. Psychiatr Serv 2006; 57: 5662.
  • 39
    Sajatovic M, Shelton MD, Elhaj O et al. Treatment Adherence in Patients with Rapid Cycling Bipolar Disorder: Results from a Clinical Trials Setting. American Psychiatric Association Annual meeting. Poster presentation, Atlanta, Georgia; 2005.